Ubs Group Ag Alpha Tau Medical Ltd. Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Ubs Group Ag holds 33,319 shares of DRTS stock, worth $125,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,319
Previous 33,019
0.91%
Holding current value
$125,945
Previous $82,000
25.61%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding DRTS
# of Institutions
30Shares Held
2MCall Options Held
0Put Options Held
0-
High Tower Advisors, LLC Chicago, IL687KShares$2.6 Million0.0% of portfolio
-
Hoyle Cohen, LLC269KShares$1.02 Million0.05% of portfolio
-
Kovitz Investment Group Partners, LLC205KShares$774,2720.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY193KShares$727,7020.06% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il66.5KShares$251,2900.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $261M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...